SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹83 Cr | ₹-45 Cr | ₹-27 Cr | ₹-18 Cr | ₹-23 Cr |
What is the latest Cash Flow from Investing Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹83 Cr |
Mar2023 | ₹-45 Cr |
Mar2022 | ₹-27 Cr |
Mar2017 | ₹-18 Cr |
Mar2016 | ₹-23 Cr |
How is Cash Flow from Investing Activities of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹83 Cr | Positive | |
Mar2023 | ₹-45 Cr | Negative | |
Mar2022 | ₹-27 Cr | Negative | |
Mar2017 | ₹-18 Cr | Negative | |
Mar2016 | ₹-23 Cr | - |
Compare Cash Flow from Investing Activities of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,614.0 Cr | 4.4% | 12.6% | 44.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 4.4% |
12.6% |
44.3% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses